From the anesthesiologist point of view, the growing number of patients treated with incretin-based therapies undergoing deep sedation and general anesthesia uncover the possible dark side of these drugs such as revealed by many case reports documenting the association between general anesthesia and gastric aspiration of a large amount of gastric content (including undigested food particles) in patients taking GLP1-RAs during the peri-operative period [10,11,12]
Research shows that the cjc/ipa mix can increase growth hormone levels by 300-500% or more, with corresponding increases in IGF-1 (insulin-like growth factor 1), the main mediator of growth hormones effects
Unfortunately, the peptide has yet to undergo thorough clinical testing, and the only clinical trial performed on patients with inflammatory bowel disease (IBD) has not been published [28]
Virslerin beslenme, nefes alma ve reme gibi metabolik faaliyetleri yoktur
In addition, the FLOW clinical trial reported a high granularity of data, and this enabled accurate modeling of both risk factors and resource use